Prosthetic Joint Infection Referral Center of Saint Étienne University Hospital, France; Unité Inserm SAINBIOSE U1059-Laboratoire de Biologie du Tissu Ostéoarticulaire, France.
Prosthetic Joint Infection Referral Center of Saint Étienne University Hospital, France; Groupe Immunité Muqueuse et Agents Pathogènes, EA 3064, CHU de Saint Etienne, 42055 Saint Étienne cedex 2, France.
Orthop Traumatol Surg Res. 2021 Feb;107(1S):102774. doi: 10.1016/j.otsr.2020.102774. Epub 2020 Dec 13.
Prosthetic joint infection (PJI) is a rare-and dreaded-complication of arthroplasty requiring multidisciplinary care. Given the dual goal of treating the infection and maintaining satisfactory function, it is preferable to determine how and when the implanted components can be retained. Bacteria and fungi organize themselves into biofilms that shield them from antibiotics and the immune system. This biofilm is in place after 15 days of active infection. Some antibiotics have a better activity on biofilms. The following factors have a negative impact on the probability of a successful debridement, antibiotics and implant retention (DAIR) intervention: fracture or revision, use of cement, bacteremia, kidney and/or liver failure, immunosuppression and elevated CRP. Hematogenous infections have a worse prognosis than early postoperative infections. Using a decision algorithm increases the chances of DAIR being successful. The KLIC score applies to early postoperative infections (<4 weeks postoperative and<3 weeks from the first signs) while the CRIME-80 score applies to hematogenous infections (<3 weeks from the first signs). Arthroscopic treatments have no role here, whereas DAIR through an arthrotomy is well standardized. Wide spectrum antibiotic therapy, secondarily adapted to the causative microorganism, is indicated for a total of 3 months. The results against the infection are mixed, although following a decision algorithm resolves the infection in about 75% of cases. The functional outcomes and quality of life are close to those of patients who have undergone primary joint replacement. It is not recommended to carry out a second DAIR if the first one fails. It is logical to apply the principles set out for the hip and knee to other joint replacements, and to use the same algorithm. For the upper limb, and especially for reverse shoulder arthroplasty, one must be careful about Cutibacterium acnes infections as they are hard to diagnose. Surgeons should not hesitate to contact a referral center for any PJI, although it is preferable that early infections be treated at the facility that performed the implantation.
人工关节感染(PJI)是关节置换术后罕见但令人恐惧的并发症,需要多学科治疗。鉴于治疗感染和维持满意功能的双重目标,最好确定何时以及如何保留植入物。细菌和真菌会形成生物膜,从而使它们免受抗生素和免疫系统的影响。这种生物膜在活跃感染 15 天后形成。一些抗生素对生物膜有更好的活性。以下因素会对清创、抗生素和植入物保留(DAIR)干预的成功率产生负面影响:骨折或翻修、使用水泥、菌血症、肾和/或肝功能衰竭、免疫抑制和 CRP 升高。血源性感染的预后比术后早期感染更差。使用决策算法可增加 DAIR 成功的机会。KLIC 评分适用于术后早期感染(术后<4 周且距首次症状<3 周),而 CRIME-80 评分适用于血源性感染(距首次症状<3 周)。关节镜治疗在这里没有作用,而通过关节切开术进行 DAIR 已经得到很好的标准化。广谱抗生素治疗,其次是针对病原体,总共需要 3 个月。针对感染的治疗效果参差不齐,尽管遵循决策算法可使大约 75%的病例的感染得到解决。功能结果和生活质量接近初次关节置换的患者。如果第一次 DAIR 失败,不建议再次进行。将髋关节和膝关节的原则应用于其他关节置换并使用相同的算法是合理的。对于上肢,尤其是对于反向肩关节置换,必须小心处理难以诊断的痤疮丙酸杆菌感染。对于任何 PJI,外科医生都应毫不犹豫地联系转诊中心,但最好在进行植入的机构治疗早期感染。